In this video exclusive, Pol Boudes, MD, chief medical officer of Galectin Therapeutics, spoke about NAVIGATEnash.com, a website for physicians and patients to get information on cirrhosis stemming from nonalcoholic steatohepatitis.

Four of five patients with relapsed or refractory B-cell lymphoma demonstrated complete response to an investigational anti-CD19/CD20 chimeric antigen receptor T-cell therapy, according to early data from a phase 1 trial.

The U.S. Preventive Services Task Force said there is not enough evidence to assess the balance of benefits and harms of vitamin D deficiency screening in nonpregnant, asymptomatic adults.

Throughout the COVID-19 pandemic, operational challenges have led to an increased trend in transactions among medical practices, according to a presenter at the Physician Transactions Conference.

Dapagliflozin is equally as effective in women as in men in reducing risk for worsening HF, CV death and all-cause death compared with placebo, according to new data from the DAPA-HF trial.

Amid positive results from large clinical trials confirming the benefits of transcatheter aortic valve replacement, along with expanded indications from the FDA, recently updated recommendations represent the already widespread acceptance of less invasive interventions for aortic stenosis.

NOV03 met the primary and secondary endpoints in its first phase 3 trial, according to a press release from Bausch + Lomb and Novaliq.

Among older individuals, better baseline CV health was associated with lower risk for incident atrial fibrillation, researchers reported.

The CDC and FDA recommended Tuesday that the U.S. “pause” the rollout of Johnson & Johnson’s COVID-19 vaccine until experts can review six reported cases of “a rare and severe type of blood clot” in people who have received the vaccine.

Women with ovarian cancer appeared to be at greater risk for anxiety, depression and adjustment disorder within the first 2 years of diagnosis than women in the general population, study results showed.